Cross-Border Healthcare

The [World Health Statistics Report 2025] released by the World Health Organization reveals the profound impact of the COVID-19 pandemic on human life loss, life expectancy, and overall health and well-being. In just two years from 2019 to 2021, the global average life expectancy fell by 1.8 years, the largest drop in modern history, reversing the progress made by humans in the health field over the past decade. Rising levels of anxiety and depression related to the COVID-19 pandemic have led to a 6-week reduction in global healthy life expectancy, offsetting most of the benefits of a decline in mortality from non-communicable diseases during the same period. 

Not only that, inflation in various countries in the post-epidemic era has also greatly increased the burden on global families on healthcare expenses.​

​

Medical services mainly depend on equipment and experience. Our cooperative hospitals not only have the world's top medical equipment, such as the da Vinci surgical robot, proton therapy system and PET-CT, which are used for the precise diagnosis and treatment of cancer, cardiovascular disease and neurological diseases. China is also a global leader in genetic testing, AI-assisted diagnosis and minimally invasive surgery. For example, the accuracy of AI in early screening of lung cancer can reach more than 90%. More importantly, Chinese doctors see an average of 50-100 patients per day, which is much higher than Europe and the United States (10-30 patients per day), and have accumulated rich experience in diagnosing difficult and complicated diseases. Chinese doctors have obvious professional advantages in the fields of cancer, cardiovascular disease, orthopedics and neurological diseases, and are particularly suitable for dealing with common and difficult diseases of patients.

​

Help global patients and insurance companies connect with the most cost-effective healthcare resources, which is our consistent service mission.